ATE419854T1 - Verfahren zur herstellung einer latanoprost- augenlösung und so hergestellte lösung - Google Patents
Verfahren zur herstellung einer latanoprost- augenlösung und so hergestellte lösungInfo
- Publication number
- ATE419854T1 ATE419854T1 AT04748557T AT04748557T ATE419854T1 AT E419854 T1 ATE419854 T1 AT E419854T1 AT 04748557 T AT04748557 T AT 04748557T AT 04748557 T AT04748557 T AT 04748557T AT E419854 T1 ATE419854 T1 AT E419854T1
- Authority
- AT
- Austria
- Prior art keywords
- solution
- preparing
- produced
- latanoprost eye
- latanoprost
- Prior art date
Links
- GGXICVAJURFBLW-CEYXHVGTSA-N latanoprost Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1 GGXICVAJURFBLW-CEYXHVGTSA-N 0.000 title 1
- 229960001160 latanoprost Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/MX2004/000034 WO2005115401A1 (es) | 2004-05-26 | 2004-05-26 | Un método para preparar una solución oftálmica de latanoprost y solución resultante |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE419854T1 true ATE419854T1 (de) | 2009-01-15 |
Family
ID=35450648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04748557T ATE419854T1 (de) | 2004-05-26 | 2004-05-26 | Verfahren zur herstellung einer latanoprost- augenlösung und so hergestellte lösung |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US8293789B2 (de) |
| EP (1) | EP1759702B1 (de) |
| AR (1) | AR049113A1 (de) |
| AT (1) | ATE419854T1 (de) |
| BR (1) | BRPI0418866A (de) |
| DE (1) | DE602004018990D1 (de) |
| DK (1) | DK1759702T3 (de) |
| ES (1) | ES2320770T3 (de) |
| PL (1) | PL1759702T3 (de) |
| PT (1) | PT1759702E (de) |
| SI (1) | SI1759702T1 (de) |
| WO (1) | WO2005115401A1 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8609634B2 (en) * | 2007-05-16 | 2013-12-17 | Mcneil-Ppc, Inc. | Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods |
| US9579341B2 (en) | 2007-05-16 | 2017-02-28 | Johnson & Johnson Consumer Inc. | Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods |
| WO2009007828A1 (en) * | 2007-07-11 | 2009-01-15 | Ophthalmopharma Ag | Complexes of prostaglandin derivatives and monosubstituted, charged beta-cyclodextrins |
| CA3014633C (en) | 2007-10-08 | 2022-05-17 | Aurinia Pharmaceuticals Inc. | Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors |
| US8455547B2 (en) * | 2008-02-05 | 2013-06-04 | Allergan, Inc. | Substituted cyclopentanes having prostaglandin activity |
| ITRM20080182A1 (it) * | 2008-04-07 | 2009-10-08 | Medivis S R L | Preparato oftalmico a base di dorzolamide e latanoprost per il trattamento topico del glaucoma. |
| US9481856B2 (en) * | 2008-06-09 | 2016-11-01 | Bausch & Lomb Incorporated | Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide |
| WO2010053487A1 (en) * | 2008-11-07 | 2010-05-14 | Cydex Pharmaceuticals, Inc. | Composition containing sulfoalkyl ether cyclodextrin and latanoprost |
| WO2010089355A1 (en) * | 2009-02-04 | 2010-08-12 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration |
| DE102009021372A1 (de) * | 2009-05-14 | 2010-11-18 | Ursapharm Arzneimittel Gmbh | Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung |
| ES2537385T3 (es) * | 2009-06-09 | 2015-06-08 | Aurinia Pharmaceuticals Inc. | Sistemas de suministro tópico para uso oftálmico |
| US8952051B2 (en) * | 2009-11-05 | 2015-02-10 | Allergan, Inc. | Ophthalmic formulations containing substituted gamma lactams and methods for use thereof |
| US20110136872A1 (en) * | 2009-12-09 | 2011-06-09 | Burk Robert M | Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof |
| US10272040B2 (en) | 2010-08-12 | 2019-04-30 | Nanyang Technological University | Liposomal formulation for ocular drug delivery |
| DE102011108948A1 (de) * | 2011-07-29 | 2013-01-31 | Achim Göpferich | Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen |
| EP2567689A1 (de) * | 2011-09-12 | 2013-03-13 | Visiotact Pharma | Ophthalmische Zusammensetzungen enhaltend Prostaglandin-F2-alpha-Derivate und Hyaluronsäure |
| US9956195B2 (en) | 2014-01-07 | 2018-05-01 | Nanyang Technological University | Stable liposomal formulations for ocular drug delivery |
| ES2669446B1 (es) * | 2016-11-24 | 2019-03-13 | Saiz Manuel Munoz | Producto oftálmico |
| US20190224275A1 (en) | 2017-05-12 | 2019-07-25 | Aurinia Pharmaceuticals Inc. | Protocol for treatment of lupus nephritis |
| GR1009419B (el) * | 2017-11-07 | 2018-12-14 | Φαρματεν Αβεε | Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου |
| JP2022519580A (ja) * | 2019-02-06 | 2022-03-24 | ティアークリアー コープ． | 複合体化剤を含む眼科用製剤から防腐剤を除去するためのシステムおよび方法 |
| KR20220044248A (ko) | 2019-08-07 | 2022-04-07 | 아네이라 파마, 인코포레이티드 | 탈모의 치료를 위한 방법 및 조성물 |
| US20230338541A1 (en) * | 2020-06-21 | 2023-10-26 | i.com medical GmbH | Use of high molecular weight hyaluronic acid as ocular transporting vehicle |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU665287B2 (en) | 1992-12-21 | 1995-12-21 | Alcon Laboratories, Inc. | Prostaglandin combinations in glaucoma therapy |
| US5631287A (en) | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
| US6646001B2 (en) * | 1997-12-19 | 2003-11-11 | Alcon Manufacturing, Ltd. | Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension |
| CA2356912C (en) * | 1998-12-25 | 2009-02-24 | Ryuji Ueno | Pharmaceutical compositions for the treatment of ocular hypertension or glaucoma |
| AU3328601A (en) * | 2000-02-01 | 2001-08-14 | Cayman Chemical Co Inc | Internal 1,15-lactones of fluprostenol and related prostaglandin F<sub>2alpha</sub> analogs and their use in the treatment of glaucoma and intraocular hypertension |
| US7115279B2 (en) * | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| PE20020578A1 (es) * | 2000-10-10 | 2002-08-14 | Upjohn Co | Una composicion de antibiotico topico para el tratamiento de infecciones oculares |
| US20030018079A1 (en) * | 2000-11-13 | 2003-01-23 | Richardson Helene | Treatment |
-
2004
- 2004-05-26 PL PL04748557T patent/PL1759702T3/pl unknown
- 2004-05-26 US US11/597,459 patent/US8293789B2/en active Active
- 2004-05-26 EP EP04748557A patent/EP1759702B1/de not_active Expired - Lifetime
- 2004-05-26 WO PCT/MX2004/000034 patent/WO2005115401A1/es active Application Filing
- 2004-05-26 BR BRPI0418866-7A patent/BRPI0418866A/pt not_active IP Right Cessation
- 2004-05-26 PT PT04748557T patent/PT1759702E/pt unknown
- 2004-05-26 AT AT04748557T patent/ATE419854T1/de active
- 2004-05-26 SI SI200431084T patent/SI1759702T1/sl unknown
- 2004-05-26 DE DE602004018990T patent/DE602004018990D1/de not_active Expired - Lifetime
- 2004-05-26 ES ES04748557T patent/ES2320770T3/es not_active Expired - Lifetime
- 2004-05-26 DK DK04748557T patent/DK1759702T3/da active
-
2005
- 2005-05-24 AR ARP050102140A patent/AR049113A1/es not_active Application Discontinuation
-
2011
- 2011-01-03 US US12/983,736 patent/US20110105605A1/en not_active Abandoned
- 2011-01-03 US US12/983,721 patent/US20110098354A1/en not_active Abandoned
- 2011-01-03 US US12/983,751 patent/US20110098355A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DK1759702T3 (da) | 2009-04-20 |
| AR049113A1 (es) | 2006-06-28 |
| EP1759702A1 (de) | 2007-03-07 |
| PT1759702E (pt) | 2009-04-13 |
| US20110098355A1 (en) | 2011-04-28 |
| SI1759702T1 (sl) | 2009-06-30 |
| US8293789B2 (en) | 2012-10-23 |
| US20110105605A1 (en) | 2011-05-05 |
| BRPI0418866A (pt) | 2007-11-20 |
| ES2320770T3 (es) | 2009-05-28 |
| DE602004018990D1 (de) | 2009-02-26 |
| US20080021101A1 (en) | 2008-01-24 |
| WO2005115401A1 (es) | 2005-12-08 |
| EP1759702B1 (de) | 2009-01-07 |
| PL1759702T3 (pl) | 2009-06-30 |
| US20110098354A1 (en) | 2011-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE419854T1 (de) | Verfahren zur herstellung einer latanoprost- augenlösung und so hergestellte lösung | |
| DE602005012823D1 (de) | Schmirgelleinen und verfahren zur herstellung einer nanofaserstruktur | |
| ATE408609T1 (de) | Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden | |
| ATE516816T1 (de) | Verfahren zur herstellung von impfstoffen | |
| DE602005020148D1 (de) | Verfahren zur herstellung einer mems-vorrichtung | |
| DE602005019848D1 (de) | Verfahren zur herstellung von tad- getrocknetem ti | |
| ATE479409T1 (de) | Verfahren zur herstellung von saugkernen | |
| ATE427997T1 (de) | Verfahren zur herstellung von alkylestern | |
| DE602005018601D1 (de) | Verfahren zur herstellung von 2-aminothiazol-5-aro | |
| DE502005010038D1 (de) | Verfahren zur herstellung von 3-pentennitril | |
| DE502005002059D1 (de) | Verfahren zur herstellung von polyetheralkoholen | |
| DE502005005281D1 (de) | Verfahren zur herstellung einer nockenwelle | |
| DE602005003082D1 (de) | Verfahren zur Herstellung einer Vorrichtung | |
| ATE406372T1 (de) | Verfahren zur herstellung von 3-o-geschützten morphinonen und 3-o-geschützten morphinondienolcarboxylaten | |
| ATE549314T1 (de) | Verfahren zur herstellung von 4-aminochinazolinen | |
| DE502005006608D1 (de) | Verfahren zur herstellung einer steckverbindung | |
| DE602005014893D1 (de) | Verfahren zur herstellung eines pvp-fulleren-komplexes und wässrige lösung davon | |
| DE502005001066D1 (de) | Nockenwelle und verfahren zur herstellung einer nockenwelle | |
| DE602005025849D1 (de) | Verfahren und Vorrichtung zur Herstellung einer Durchgangsbohrung | |
| DE602004027229D1 (de) | Verfahren zur herstellung von photonischer kristallfaser | |
| ATE542533T1 (de) | Verfahren zur herstellung von isothiazol- derivaten | |
| ATE460414T1 (de) | Verfahren zur herstellung von tiotropiumsalzen | |
| ATE438613T1 (de) | Verfahren zur herstellung von anilinen | |
| DE502004003171D1 (de) | Verfahren zur herstellung von bauteilen einer gastubine | |
| DE602006000087D1 (de) | Verfahren zur Herstellung von Mustern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1759702 Country of ref document: EP |